Probiotics in the Management of Surgery- Induced Diarrhea: Efficacy and Clinical Applications

Surgery-induced diarrhea (SID) is a frequent consequence of gastrointestinal procedures that is frequently brought on by disruptions to the microbiota, modifications to gut permeability, and changes in gut motility. It may cause severe morbidity, hindered healing, prolonged hospital stays, and higher medical expenses. Probiotics are live bacteria that, when given in sufficient quantities, offer health advantages. As a result, they have gained attention as a possible treatment strategy to lessen SID. Probiotics may reduce SID through a number of methods, including altered gut microbiome, improved mucosal barrier function, and pathogen suppression. In numerous clinical trials, probiotics like Lactobacillus, Bifidobacterium, and Saccharomyces boulardii have shown encouraging outcomes in lowering the frequency, length, and severity of postoperative diarrhea. Probiotics have also been linked to decrease inflammatory responses and enhanced immunological function, both of which are crucial in the post-surgical context. However, a number of variables, like the particular strains utilized, the dosage, the length of time of administration, and the patient's initial state of health and microbiome composition, affect how well probiotics work to manage SID. Even though the available data points to a positive safety profile for probiotics, especially in patients who are immunocompetent, more extensive randomized controlled trials are required to create standard recommendations for their application in clinical practice. This review examines the effectiveness of probiotics and their clinical uses in the treatment of Surgery induced diarrhea.